title: Enhancing the antitumor effects of radiotherapy with combinations of immunostimulatory antibodies.
abstract: The development and use of combination immunotherapy-based anticancer regimens is at an early but clearly exciting stage. We now demonstrate that the antibody-based co-targeting of multiple immunostimulatory and/or inhibitory pathways can be used safely and effectively in combination with single dose or fractionated radiotherapy to cure mice bearing established mammary tumors.
authors.affiliation: Division of Cell Biology II; The Netherlands Cancer Institute; Amsterdam, The Netherlands.
authors.forename: Inge
authors.initials: I
authors.lastname: Verbrugge
authors.forename: Mara
authors.initials: M
authors.lastname: Galli
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Smyth
authors.forename: Ricky W
authors.initials: RW
authors.lastname: Johnstone
authors.forename: Nicole M
authors.initials: NM
authors.lastname: Haynes